Table of Contents
ISRN Hematology
Volume 2011 (2011), Article ID 921706, 9 pages
http://dx.doi.org/10.5402/2011/921706
Review Article

Notch Signaling in T-Cell Development and T-ALL

Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA

Received 5 November 2010; Accepted 15 December 2010

Academic Editors: A. M. Will, H. Strobl, and T. Yokota

Copyright © 2011 Xiaoyu Li and Harald von Boehmer. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. H. Morgan, “The theory of the gene,” The American Naturalist, vol. 51, pp. 513–544, 1917. View at Google Scholar
  2. K. A. Wharton, K. M. Johansen, T. Xu, and S. Artavanis-Tsakonas, “Nucleotide sequence from the neurogenic locus Notch implies a gene product that shares homology with proteins containing EGF-like repeats,” Cell, vol. 43, no. 3, part 2, pp. 567–581, 1985. View at Google Scholar · View at Scopus
  3. S. Kidd, M. R. Kelley, and M. W. Young, “Sequence of the notch locus of Drosophila melanogaster: relationship of the encoded protein to mammalian clotting and growth factors,” Molecular and Cellular Biology, vol. 6, no. 9, pp. 3094–3108, 1986. View at Google Scholar · View at Scopus
  4. S. Artavanis-Tsakonas, M. D. Rand, and R. J. Lake, “Notch signaling: cell fate control and signal integration in development,” Science, vol. 284, no. 5415, pp. 770–776, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. L. W. Ellisen, J. Bird, D. C. West et al., “TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms,” Cell, vol. 66, no. 4, pp. 649–661, 1991. View at Publisher · View at Google Scholar · View at Scopus
  6. F. F. Del Amo, D. E. Smith, P. J. Swiatek et al., “Expression pattern of Motch, a mouse homolog of Drosophila Notch, suggests an important role in early postimplantation mouse development,” Development, vol. 115, no. 3, pp. 737–744, 1992. View at Google Scholar · View at Scopus
  7. G. Weinmaster, V. J. Roberts, and G. Lemke, “Notch2: a second mammalian Notch gene,” Development, vol. 116, no. 4, pp. 931–941, 1992. View at Google Scholar · View at Scopus
  8. M. Lardelli and U. Lendahl, “Motch A and Motch B—two mouse Notch homologues coexpressed in a wide variety of tissues,” Experimental Cell Research, vol. 204, no. 2, pp. 364–372, 1993. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Lardelli, J. Dahlstrand, and U. Lendahl, “The novel Notch homologue mouse Notch 3 lacks specific epidermal growth factor-repeats and is expressed in proliferating neuroepithelium,” Mechanisms of Development, vol. 46, no. 2, pp. 123–136, 1994. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Uyttendaele, G. Marazzi, G. Wu, Q. Yan, D. Sassoon, and J. Kitajewski, “Notch4/int-3, a mammary proto-oncogene, is an endothelial cell-specific mammalian Notch gene,” Development, vol. 122, no. 7, pp. 2251–2259, 1996. View at Google Scholar · View at Scopus
  11. B. Bettenhausen, M. Hrabe de Angelis, D. Simon, J. L. Guenet, and A. Gossler, “Transient and restricted expression during mouse embryogenesis of Dll1, a murine gene closely related to Drosophila Delta,” Development, vol. 121, no. 8, pp. 2407–2418, 1995. View at Google Scholar · View at Scopus
  12. S. L. Dunwoodie, D. Henrique, S. M. Harrison, and R. S. P. Beddington, “Mouse Dll3: a novel divergent Delta gene which may complement the function of other Delta homologues during early pattern formation in the mouse embryo,” Development, vol. 124, no. 16, pp. 3065–3076, 1997. View at Google Scholar · View at Scopus
  13. C. E. Lindsell, C. J. Shawber, J. Boulter, and G. Weinmaster, “Jagged: a mammalian ligand that activates Notch1,” Cell, vol. 80, no. 6, pp. 909–917, 1995. View at Google Scholar · View at Scopus
  14. C. Shawber, J. Boulter, C. E. Lindsell, and G. Weinmaster, “Jagged2: a Serrate-like gene expressed during rat embryogenesis,” Developmental Biology, vol. 180, no. 1, pp. 370–376, 1996. View at Publisher · View at Google Scholar · View at Scopus
  15. J. R. Shutter, S. Scully, W. Fan et al., “D114, a novel Notch ligand expressed in arterial endothelium,” Genes and Development, vol. 14, no. 11, pp. 1313–1318, 2000. View at Google Scholar · View at Scopus
  16. J. C. Aster, W. S. Pear, and S. C. Blacklow, “Notch signaling in leukemia,” Annual Review of Pathology, vol. 3, pp. 587–613, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. C. M. Blaumueller, H. Qi, P. Zagouras, and S. Artavanis-Tsakonas, “Intracellular cleavage of Notch leads to a heterodimeric receptor on the plasma membrane,” Cell, vol. 90, no. 2, pp. 281–291, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. I. Rebay, R. J. Fleming, R. G. Fehon, L. Cherbas, P. Cherbas, and S. Artavanis-Tsakonas, “Specific EGF repeats of Notch mediate interactions with Delta and Serrate: implications for Notch as a multifunctional receptor,” Cell, vol. 67, no. 4, pp. 687–699, 1991. View at Google Scholar · View at Scopus
  19. C. Sanchez-Irizarry, A. C. Carpenter, A. P. Weng, W. S. Pear, J. C. Aster, and S. C. Blacklow, “Notch subunit heterodimerization and prevention of ligand-independent proteolytic activation depend, respectively, on a novel domain and the LNR repeats,” Molecular and Cellular Biology, vol. 24, no. 21, pp. 9265–9273, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Kopan and M. X. G. Ilagan, “The canonical Notch signaling pathway: unfolding the activation mechanism,” Cell, vol. 137, no. 2, pp. 216–233, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. M. E. Fortini and S. Artavanis-Tsakonas, “The suppressor of hairless protein participates in notch receptor signaling,” Cell, vol. 79, no. 2, pp. 273–282, 1994. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Tamura, Y. Taniguchi, S. Minoguchi et al., “Physical interaction between a novel domain of the receptor Notch and the transcription factor RBP-Jkappa/Su(H),” Current Biology, vol. 5, no. 12, pp. 1416–1423, 1995. View at Publisher · View at Google Scholar · View at Scopus
  23. N. Gupta-Rossi, O. Le Bail, H. Gonen et al., “Functional interaction between SEL-10, an F-box protein, and the nuclear form of activated Notch1 receptor,” Journal of Biological Chemistry, vol. 276, no. 37, pp. 34371–34378, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Öberg, J. Li, A. Pauley, E. Wolf, M. Gurney, and U. Lendahl, “The Notch intracellular domain is ubiquitinated and negatively regulated by the mammalian Sel-10 homolog,” Journal of Biological Chemistry, vol. 276, no. 38, pp. 35847–35853, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. B. de Strooper, W. Annaert, P. Cupers et al., “A presenilin-1-dependent γ-secretase-like protease mediates release of notch intracellular domain,” Nature, vol. 398, no. 6727, pp. 518–522, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Struhl and A. Adachi, “Nuclear access and action of Notch in vivo,” Cell, vol. 93, no. 4, pp. 649–660, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Y. Kao, P. Ordentlich, N. Koyano-Nakagawa et al., “A histone deacetylase corepressor complex regulates the Notch signal transduction pathway,” Genes and Development, vol. 12, no. 15, pp. 2269–2277, 1998. View at Google Scholar · View at Scopus
  28. F. Oswald, M. Winkler, Y. Cao et al., “RBP-Jκ/SHARP recruits CtIP/CtBP corepressors to silence notch target genes,” Molecular and Cellular Biology, vol. 25, no. 23, pp. 10379–10390, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Wu, J. C. Aster, S. C. Blacklow, R. Lake, S. Artavanis-Tsakonas, and J. D. Griffin, “MAML1, a human homologue of Drosophila mastermind, is a transcriptional co-activator for NOTCH receptors,” Nature Genetics, vol. 26, no. 4, pp. 484–489, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. L. Wu, T. Sun, K. Kobayashi, P. Gao, and J. D. Griffin, “Identification of a family of mastermind-like transcriptional coactivators for mammalian Notch receptors,” Molecular and Cellular Biology, vol. 22, no. 21, pp. 7688–7700, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Kurooka and T. Honjo, “Functional interaction between the mouse Notch1 intracellular region and histone acetyltransferases PCAF and GCN5,” Journal of Biological Chemistry, vol. 275, no. 22, pp. 17211–17220, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Brückner, L. Perez, H. Clausen, and S. Cohen, “Glycosyltransferase activity of Fringe modulates Notch-Delta interactions,” Nature, vol. 406, no. 6794, pp. 411–415, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. D. J. Moloney, V. M. Panin, S. H. Johnston et al., “Fringe is a glycosyltransferase that modifies Notch,” Nature, vol. 406, no. 6794, pp. 369–375, 2000. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Munro and M. Freeman, “The Notch signalling regulator Fringe acts in the Golgi apparatus and requires the glycosyltransferase signature motif DxD,” Current Biology, vol. 10, no. 14, pp. 813–820, 2000. View at Publisher · View at Google Scholar · View at Scopus
  35. N. Haines and K. D. Irvine, “Glycosylation regulates Notch signalling,” Nature Reviews Molecular Cell Biology, vol. 4, no. 10, pp. 786–797, 2003. View at Google Scholar · View at Scopus
  36. U. Koch, J. S. Yuan, J. A. Harper, and C. J. Guidos, “Fine-tuning Notch1 activation by endocytosis and glycosylation,” Seminars in Immunology, vol. 15, no. 2, pp. 99–106, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. U. Koch, T. A. Lacombe, D. Holland et al., “Subversion of the T/B lineage decision in the thymus by Lunatic Fringe-mediated inhibition of Notch-1,” Immunity, vol. 15, no. 2, pp. 225–236, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. R. Kopan and M. X. G. Ilagan, “γ-secretase: proteasome of the membrane?” Nature Reviews Molecular Cell Biology, vol. 5, no. 6, pp. 499–504, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. H. D. Lewis, M. Leveridge, P. R. Strack et al., “Apoptosis in T cell acute lymphoblastic leukemia cells after cell cycle arrest induced by pharmacological inhibition of notch signaling,” Chemistry and Biology, vol. 14, no. 2, pp. 209–219, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. I. Maillard, L. Tu, A. Sambandam et al., “The requirement for Notch signaling at the β-selection checkpoint in vivo is absolute and independent of the pre-T cell receptor,” Journal of Experimental Medicine, vol. 203, no. 10, pp. 2239–2245, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. Nam, A. P. Weng, J. C. Aster, and S. C. Blacklow, “Structural requirements for assembly of the CSL·intracellular Notch1·Mastermind-like 1 transcriptional activation complex,” Journal of Biological Chemistry, vol. 278, no. 23, pp. 21232–21239, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. L. Tu, T. C. Fang, D. Artis et al., “Notch signaling is an important regulator of type 2 immunity,” Journal of Experimental Medicine, vol. 202, no. 8, pp. 1037–1042, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. I. Maillard, A. P. Weng, A. C. Carpenter et al., “Mastermind critically regulates Notch-mediated lymphoid cell fate decisions,” Blood, vol. 104, no. 6, pp. 1696–1702, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. J. O'Neil, J. Grim, P. Strack et al., “FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors,” Journal of Experimental Medicine, vol. 204, no. 8, pp. 1813–1824, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. B. J. Thompson, S. Buonamici, M. L. Sulis et al., “The SCF ubiquitin ligase complex as a tumor suppressor in T cell leukemia,” Journal of Experimental Medicine, vol. 204, no. 8, pp. 1825–1835, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. B. J. Thompson, V. Jankovic, J. Gao et al., “Control of hematopoietic stem cell quiescence by the E3 ubiquitin ligase Fbw7,” Journal of Experimental Medicine, vol. 205, no. 6, pp. 1395–1408, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. C. J. Fryer, J. B. White, and K. A. Jones, “Mastermind recruits CycC:CDK8 to phosphorylate the Notch ICD and coordinate activation with turnover,” Molecular Cell, vol. 16, no. 4, pp. 509–520, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. H. Han, K. Tanigaki, N. Yamamoto et al., “Inducible gene knockout of transcription factor recombination signal binding protein-J reveals its essential role in T versus B lineage decision,” International Immunology, vol. 14, no. 6, pp. 637–645, 2002. View at Google Scholar · View at Scopus
  49. F. Radtke, A. Wilson, G. Stark et al., “Deficient T cell fate specification in mice with an induced inactivation of Notch1,” Immunity, vol. 10, no. 5, pp. 547–558, 1999. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Wilson, H. R. MacDonald, and F. Radtke, “Notch 1-deficient common lymphoid precursors adopt a B cell fate in the thymus,” Journal of Experimental Medicine, vol. 194, no. 7, pp. 1003–1012, 2001. View at Publisher · View at Google Scholar · View at Scopus
  51. J. C. Pui, D. Allman, L. Xu et al., “Notch1 expression in early lymphopoiesis influences B versus T lineage determination,” Immunity, vol. 11, no. 3, pp. 299–308, 1999. View at Publisher · View at Google Scholar · View at Scopus
  52. N. Carlesso, J. C. Aster, J. Sklar, and D. T. Scadden, “Notch1-induced delay of human hematopoietic progenitor cell differentiation is associated with altered cell cycle kinetics,” Blood, vol. 93, no. 3, pp. 838–848, 1999. View at Google Scholar · View at Scopus
  53. L. Li, L. A. Milner, Y. Deng et al., “The human homolog of rat Jagged1 expressed by marrow stroma inhibits differentiation of 32D cells through interaction with Notch1,” Immunity, vol. 8, no. 1, pp. 43–55, 1998. View at Publisher · View at Google Scholar · View at Scopus
  54. L. A. Milner, A. Bigas, R. Kopan, C. Brashem-Stein, I. D. Bernstein, and D. I. K. Martin, “Inhibition of granulocytic differentiation by mNotch1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 23, pp. 13014–13019, 1996. View at Publisher · View at Google Scholar · View at Scopus
  55. S. Stier, T. Cheng, D. Dombkowski, N. Carlesso, and D. T. Scadden, “Notch1 activation increases hematopoietic stem cell self-renewal in vivo and favors lymphoid over myeloid lineage outcome,” Blood, vol. 99, no. 7, pp. 2369–2378, 2002. View at Publisher · View at Google Scholar · View at Scopus
  56. D. Allman, A. Sambandam, S. Kim et al., “Thymopoiesis independent of common lymphoid progenitors,” Nature Immunology, vol. 4, no. 2, pp. 168–174, 2003. View at Publisher · View at Google Scholar · View at Scopus
  57. A. Bhandoola, A. Sambandam, D. Allman, A. Meraz, and B. Schwarz, “Early T lineage progenitors: new insights, but old questions remain,” Journal of Immunology, vol. 171, no. 11, pp. 5653–5658, 2003. View at Google Scholar · View at Scopus
  58. A. Sambandam, I. Maillard, V. P. Zediak et al., “Notch signaling controls the generation and differentiation of early T lineage progenitors,” Nature Immunology, vol. 6, no. 7, pp. 663–670, 2005. View at Publisher · View at Google Scholar · View at Scopus
  59. J. B. Tan, I. Visan, J. S. Yuan, and C. J. Guidos, “Requirement for Notch1 signals at sequential early stages of intrathymic T cell development,” Nature Immunology, vol. 6, no. 7, pp. 671–679, 2005. View at Publisher · View at Google Scholar · View at Scopus
  60. T. M. Schmitt, M. Ciofani, H. T. Petrie, and J. C. Zúñiga-Pflücker, “Maintenance of T cell specification and differentiation requires recurrent Notch receptor-ligand interactions,” Journal of Experimental Medicine, vol. 200, no. 4, pp. 469–479, 2004. View at Publisher · View at Google Scholar · View at Scopus
  61. T. N. Taghon, E. S. David, J. C. Zúñiga-Pflücker, and E. V. Rothenberg, “Delayed, asynchronous, and reversible T-lineage specification induced by Notch/Delta signaling,” Genes and Development, vol. 19, no. 8, pp. 965–978, 2005. View at Publisher · View at Google Scholar · View at Scopus
  62. T. J. Yun and M. J. Bevan, “Notch-regulated ankyrin-repeat protein inhibits Notch1 signaling: multiple Notch1 signaling pathways involved in T cell development,” Journal of Immunology, vol. 170, no. 12, pp. 5834–5841, 2003. View at Google Scholar · View at Scopus
  63. A. M. Michie and J. C. Zúñiga-Pflücker, “Regulation of thymocyte differentiation: pre-TCR signals and β-selection,” Seminars in Immunology, vol. 14, no. 5, pp. 311–323, 2002. View at Publisher · View at Google Scholar · View at Scopus
  64. H. von Boehmer, I. Aifantis, J. Feinberg et al., “Pleiotropic changes controlled by the pre-T-cell receptor,” Current Opinion in Immunology, vol. 11, no. 2, pp. 135–142, 1999. View at Publisher · View at Google Scholar · View at Scopus
  65. A. I. Garbe and H. von Boehmer, “TCR and Notch synergize in αβ versus γδ lineage choice,” Trends in Immunology, vol. 28, no. 3, pp. 124–131, 2007. View at Publisher · View at Google Scholar · View at Scopus
  66. C. Saint-Ruf, K. Ungewiss, M. Groettrup, L. Bruno, H. J. Fehling, and H. von Boehmer, “Analysis and expression of a cloned pre-T cell receptor gene,” Science, vol. 266, no. 5188, pp. 1208–1212, 1994. View at Google Scholar · View at Scopus
  67. E. C. Dudley, H. T. Petrie, L. M. Shah, M. J. Owen, and A. C. Hayday, “T cell receptor β chain gene rearrangement and selection during thymocyte development in adult mice,” Immunity, vol. 1, no. 2, pp. 63–93, 1994. View at Google Scholar · View at Scopus
  68. H. J. Fehling, A. Krotkova, C. Saint-Ruf, and H. von Boehmer, “Crucial role of the pre-T-cell receptor α gene in development of αβ but not γδ T cells,” Nature, vol. 375, no. 6534, pp. 795–798, 1995. View at Google Scholar
  69. H. J. Fehling and H. V. Boehmer, “Early αβ T cell development in the thymus of normal and genetically altered mice,” Current Opinion in Immunology, vol. 9, no. 2, pp. 263–275, 1997. View at Publisher · View at Google Scholar · View at Scopus
  70. P. Mombaerts, J. Iacomini, R. S. Johnson, K. Herrup, S. Tonegawa, and V. E. Papaioannou, “RAG-1-deficient mice have no mature B and T lymphocytes,” Cell, vol. 68, no. 5, pp. 869–877, 1992. View at Publisher · View at Google Scholar · View at Scopus
  71. Y. Shinkai, G. Rathbun, K. P. Lam et al., “RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement,” Cell, vol. 68, no. 5, pp. 855–867, 1992. View at Publisher · View at Google Scholar · View at Scopus
  72. A. Wolfer, A. Wilson, M. Nemir, H. R. MacDonald, and F. Radtke, “Inactivation of Notch1 impairs VDJβ rearrangement and allows pre-TCR-independent survival of early αβ lineage thymocytes,” Immunity, vol. 16, no. 6, pp. 869–879, 2002. View at Publisher · View at Google Scholar · View at Scopus
  73. K. Tanigaki, M. Tsuji, N. Yamamoto et al., “Regulation of αβ/γδ T cell lineage commitment and peripheral T cell responses by Notch/RBP-J signaling,” Immunity, vol. 20, no. 5, pp. 611–622, 2004. View at Publisher · View at Google Scholar · View at Scopus
  74. T. M. Schmitt and J. C. Zúñiga-Pflücker, “Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro,” Immunity, vol. 17, no. 6, pp. 749–756, 2002. View at Publisher · View at Google Scholar · View at Scopus
  75. J. C. Zúñiga-Pflücker, “T-cell development made simple,” Nature Reviews Immunology, vol. 4, no. 1, pp. 67–72, 2004. View at Google Scholar · View at Scopus
  76. M. Ciofani, T. M. Schmitt, A. Ciofani et al., “Obligatory role for cooperative signaling by pre-TCR and Notch during thymocyte differentiation,” Journal of Immunology, vol. 172, no. 9, pp. 5230–5239, 2004. View at Google Scholar · View at Scopus
  77. M. Ciofani, G. C. Knowles, D. L. Wiest, H. von Boehmer, and J. C. Zúñiga-Pflücker, “Stage-specific and differential notch dependency at the αβ and γδ T lineage bifurcation,” Immunity, vol. 25, no. 1, pp. 105–116, 2006. View at Publisher · View at Google Scholar · View at Scopus
  78. M. Ciofani and J. C. Zúñiga-Pflücker, “Notch promotes survival of pre-T cells at the β-selection checkpoint by regulating cellular metabolism,” Nature Immunology, vol. 6, no. 9, pp. 881–888, 2005. View at Publisher · View at Google Scholar · View at Scopus
  79. M. Ciofani and J. C. Zúñiga-Pflücker, “Determining γδ versus αβ T cell development,” Nature Reviews Immunology, vol. 10, no. 9, pp. 657–663, 2010. View at Publisher · View at Google Scholar
  80. T. Kreslavsky, A. I. Garbe, A. Krueger, and H. von Boehmer, “T cell receptor-instructed -αβ versus γδ lineage commitment revealed by single-cell analysis,” Journal of Experimental Medicine, vol. 205, no. 5, pp. 1173–1186, 2008. View at Publisher · View at Google Scholar · View at Scopus
  81. T. Kreslavsky, M. Gleimer, and H. von Boehmer, “αβ versus γδ lineage choice at the first TCR-controlled checkpoint,” Current Opinion in Immunology, vol. 22, no. 2, pp. 185–192, 2010. View at Publisher · View at Google Scholar · View at Scopus
  82. T. Kreslavsky and H. von Boehmer, “γδ TCR ligands and lineage commitment,” Seminars in Immunology, vol. 22, no. 4, pp. 214–221, 2010. View at Publisher · View at Google Scholar
  83. A. I. Garbe, A. Krueger, F. Gounari, J. C. Zúñiga-Pflücker, and H. von Boehmer, “Differential synergy of Notch and T cell receptor signaling determines αβ versus γδ lineage fate,” Journal of Experimental Medicine, vol. 203, no. 6, pp. 1579–1590, 2006. View at Publisher · View at Google Scholar · View at Scopus
  84. R. Jiang, Y. Lan, H. D. Chapman et al., “Defects in limb, craniofacial, and thymic development in Jagged2 mutant mice,” Genes and Development, vol. 12, no. 7, pp. 1046–1057, 1998. View at Google Scholar · View at Scopus
  85. W. S. Pear, J. C. Aster, M. L. Scott et al., “Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles,” Journal of Experimental Medicine, vol. 183, no. 5, pp. 2283–2291, 1996. View at Publisher · View at Google Scholar · View at Scopus
  86. A. P. Weng, A. A. Ferrando, W. Lee et al., “Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia,” Science, vol. 306, no. 5694, pp. 269–271, 2004. View at Publisher · View at Google Scholar · View at Scopus
  87. Y. W. Lin, R. A. Nichols, J. J. Letterio, and P. D. Aplan, “Notch1 mutations are important for leukemic transformation in murine models of precursor-T leukemia/lymphoma,” Blood, vol. 107, no. 6, pp. 2540–2543, 2006. View at Publisher · View at Google Scholar · View at Scopus
  88. J. O'Neil, J. Calvo, K. McKenna et al., “Activating Notch1 mutations in mouse models of T-ALL,” Blood, vol. 107, no. 2, pp. 781–785, 2006. View at Publisher · View at Google Scholar · View at Scopus
  89. V. M. Sharma, J. A. Calvo, K. M. Draheim et al., “Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc,” Molecular and Cellular Biology, vol. 26, no. 21, pp. 8022–8031, 2006. View at Publisher · View at Google Scholar · View at Scopus
  90. C. Murre, P. Schonleber McCaw, and D. Baltimore, “A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins,” Cell, vol. 56, no. 5, pp. 777–783, 1989. View at Google Scholar · View at Scopus
  91. X. H. Sun, “Multitasking of helix-loop-helix proteins in lymphopoiesis,” Advances in Immunology, vol. 84, pp. 43–77, 2004. View at Publisher · View at Google Scholar · View at Scopus
  92. X. H. Sun and D. Baltimore, “An inhibitory domain of E12 transcription factor prevents DNA binding in E12 homodimers but not in E12 heterodimers,” Cell, vol. 64, no. 2, pp. 459–470, 1991. View at Google Scholar · View at Scopus
  93. I. Engel and C. Murre, “E2A proteins enforce a proliferation checkpoint in developing thymocytes,” The EMBO Journal, vol. 23, no. 1, pp. 202–211, 2004. View at Publisher · View at Google Scholar · View at Scopus
  94. P. Matthias and A. G. Rolink, “Transcriptional networks in developing and mature B cells,” Nature Reviews Immunology, vol. 5, no. 6, pp. 497–508, 2005. View at Publisher · View at Google Scholar · View at Scopus
  95. G. Bain, I. Engel, E. C. R. Maandag et al., “E2A deficiency leads to abnormalities in αβ T-cell development and to rapid development of T-cell lymphomas,” Molecular and Cellular Biology, vol. 17, no. 8, pp. 4782–4791, 1997. View at Google Scholar · View at Scopus
  96. P. Ordentlich, A. Lin, C. P. Shen et al., “Notch inhibition of E47 supports the existence of a novel signaling pathway,” Molecular and Cellular Biology, vol. 18, no. 4, pp. 2230–2239, 1998. View at Google Scholar · View at Scopus
  97. C. Talora, A. F. Campese, D. Bellavia et al., “Pre-TCR-triggered ERK signalling-dependent downregulation of E2A activity in Notch3-induced T-cell lymphoma,” EMBO Reports, vol. 4, no. 11, pp. 1067–1072, 2003. View at Publisher · View at Google Scholar · View at Scopus
  98. X. Li, F. Gounari, A. Protopopov, K. Khazaie, and H. von Boehmer, “Oncogenesis of T-ALL and nonmalignant consequences of overexpressing intracellular NOTCH1,” Journal of Experimental Medicine, vol. 205, no. 12, pp. 2851–2861, 2008. View at Publisher · View at Google Scholar · View at Scopus
  99. L. Nie, M. Xu, A. Vladimirova, and X. H. Sun, “Notch-induced E2A ubiquitination and degradation are controlled by MAP kinase activities,” The EMBO Journal, vol. 22, no. 21, pp. 5780–5792, 2003. View at Publisher · View at Google Scholar · View at Scopus
  100. D. S. Chervinsky, X. F. Zhao, D. H. Lam, M. Ellsworth, K. W. Gross, and P. D. Aplan, “Disordered T-cell development and T-cell malignancies in SCL LMO1 double-transgenic mice: parallels with E2A-deficient mice,” Molecular and Cellular Biology, vol. 19, no. 7, pp. 5025–5035, 1999. View at Google Scholar · View at Scopus
  101. H. L. Hsu, I. Wadman, and R. Baer, “Formation of in vivo complexes between the TAL1 and E2A polypeptides of leukemic T cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 8, pp. 3181–3185, 1994. View at Google Scholar · View at Scopus
  102. S. Herblot, A. M. Steff, P. Hugo, P. D. Aplan, and T. Hoang, “SCL and LMOI alter thymocyte differentiation: inhibition of E2A-HEB function and pre-T α chain expression,” Nature Immunology, vol. 1, no. 2, pp. 138–144, 2000. View at Google Scholar · View at Scopus
  103. J. O'Neil, J. Shank, N. Cusson, C. Murre, and M. Kelliher, “TAL1/SCL induces leukemia by inhibiting the transcriptional activity of E47/HEB,” Cancer Cell, vol. 5, no. 6, pp. 587–596, 2004. View at Publisher · View at Google Scholar · View at Scopus
  104. T. H. Rabbitts, “LMO T-cell translocation oncogenes typify genes activated by chromosomal translocations that alter transcription and developmental processes,” Genes and Development, vol. 12, no. 17, pp. 2651–2657, 1998. View at Google Scholar · View at Scopus
  105. C. Grabher, H. von Boehmer, and A. T. Look, “Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia,” Nature Reviews Cancer, vol. 6, no. 5, pp. 347–359, 2006. View at Publisher · View at Google Scholar · View at Scopus
  106. T. Palomero, K. L. Wei, D. T. Odom et al., “NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 48, pp. 18261–18266, 2006. View at Publisher · View at Google Scholar · View at Scopus
  107. A. P. Weng, J. M. Millholland, Y. Yashiro-Ohtani et al., “c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma,” Genes and Development, vol. 20, no. 15, pp. 2096–2109, 2006. View at Publisher · View at Google Scholar · View at Scopus
  108. Y. Satoh, I. Matsumura, H. Tanaka et al., “Roles for c-Myc in self-renewal of hematopoietic stem cells,” Journal of Biological Chemistry, vol. 279, no. 24, pp. 24986–24993, 2004. View at Publisher · View at Google Scholar · View at Scopus
  109. A. Klinakis, M. Szaboks, K. Politi, H. Kiaris, S. Artavanis-Tsakonas, and A. Efstratiadis, “Myc is a Notch1 transcriptional target and a requisite for Notch1-induced mammary tumorigenesis in mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 24, pp. 9262–9267, 2006. View at Publisher · View at Google Scholar · View at Scopus
  110. L. Girard, Z. Hanna, N. Beaulieu et al., “Frequent provirus insertional mutagenesis of Notch1 in thymomas of MMTV(D)/myc transgenic mice suggests a collaboration of c-myc and Notch1 for oncogenesis,” Genes and Development, vol. 10, no. 15, pp. 1930–1944, 1996. View at Google Scholar · View at Scopus
  111. T. Sanda, X. Li, A. Gutierrez et al., “Interconnecting molecular pathways in the pathogenesis and drug sensitivity of T-cell acute lymphoblastic leukemia,” Blood, vol. 115, no. 9, pp. 1735–1745, 2010. View at Publisher · View at Google Scholar · View at Scopus
  112. A. P. Weng, Y. Nam, M. S. Wolfe et al., “Growth suppression of pre-T acute lymphoblastic leukemia cells by inhibition of NOTCH signaling,” Molecular and Cellular Biology, vol. 23, no. 2, pp. 655–664, 2003. View at Publisher · View at Google Scholar · View at Scopus
  113. E. Sicinska, I. Aifantis, L. Le Cam et al., “Requirement for cyclin D3 in lymphocyte development and T cell leukemias,” Cancer Cell, vol. 4, no. 6, pp. 451–461, 2003. View at Publisher · View at Google Scholar · View at Scopus
  114. I. Joshi, L. M. Minter, J. Telfer et al., “Notch signaling mediates G/S cell-cycle progression in T cells via cyclin D3 and its dependent kinases,” Blood, vol. 113, no. 8, pp. 1689–1698, 2009. View at Publisher · View at Google Scholar · View at Scopus
  115. C. J. Sherr and J. M. Roberts, “CDK inhibitors: positive and negative regulators of G-phase progression,” Genes and Development, vol. 13, no. 12, pp. 1501–1512, 1999. View at Google Scholar · View at Scopus
  116. L. M. Sarmento, H. Huang, A. Limon et al., “Notch1 modulates timing of G-S progression by inducing SKP2 transcription and p27 degradation,” Journal of Experimental Medicine, vol. 202, no. 1, pp. 157–168, 2005. View at Publisher · View at Google Scholar · View at Scopus
  117. T. Dohda, A. Maljukova, L. Liu et al., “Notch signaling induces SKP2 expression and promotes reduction of p27Kip1 in T-cell acute lymphoblastic leukemia cell lines,” Experimental Cell Research, vol. 313, no. 14, pp. 3141–3152, 2007. View at Publisher · View at Google Scholar · View at Scopus
  118. S. S. Rao, J. O'Neil, C. D. Liberator et al., “Inhibition of NOTCH signaling by gamma secretase inhibitor engages the RB pathway and elicits cell cycle exit in T-cell acute lymphoblastic leukemia cells,” Cancer Research, vol. 69, no. 7, pp. 3060–3068, 2009. View at Publisher · View at Google Scholar · View at Scopus
  119. C. J. Sherr, “Tumor surveillance via the ARF-p53 pathway,” Genes and Development, vol. 12, no. 19, pp. 2984–2991, 1998. View at Google Scholar · View at Scopus
  120. C. M. Eischen, J. D. Weber, M. F. Roussel, C. J. Sherr, and J. L. Cleveland, “Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis,” Genes and Development, vol. 13, no. 20, pp. 2658–2669, 1999. View at Publisher · View at Google Scholar · View at Scopus
  121. L. J. Beverly, D. W. Felsher, and A. J. Capobianco, “Suppression of p53 by Notch in lymphomagenesis: implications for initiation and regression,” Cancer Research, vol. 65, no. 16, pp. 7159–7168, 2005. View at Publisher · View at Google Scholar · View at Scopus
  122. S. M. Chan, A. P. Weng, R. Tibshirani, J. C. Aster, and P. J. Utz, “Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemia,” Blood, vol. 110, no. 1, pp. 278–286, 2007. View at Publisher · View at Google Scholar · View at Scopus
  123. S. K. Mungamuri, X. Yang, A. D. Thor, and K. Somasundaram, “Survival signaling by Notch1: mammalian target of rapamycin (mTOR)-dependent inhibition of p53,” Cancer Research, vol. 66, no. 9, pp. 4715–4724, 2006. View at Publisher · View at Google Scholar · View at Scopus
  124. T. Palomero, M. L. Sulis, M. Cortina et al., “Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia,” Nature Medicine, vol. 13, no. 10, pp. 1203–1210, 2007. View at Publisher · View at Google Scholar · View at Scopus
  125. H. Medyouf, X. Gao, F. Armstrong et al., “Acute T-cell leukemias remain dependent on Notch signaling despite PTEN and INK4A/ARF loss,” Blood, vol. 115, no. 6, pp. 1175–1184, 2010. View at Publisher · View at Google Scholar · View at Scopus
  126. E. Coskun, E. K. von der Heide, C. Schlee et al., “The role of microRNA-196a and microRNA-196b as ERG regulators in acute myeloid leukemia and acute T-lymphoblastic leukemia,” Leukemia Research. In press. View at Publisher · View at Google Scholar
  127. T. Kaddar, W. W. Chien, Y. Bertrand et al., “Prognostic value of miR-16 expression in childhood acute lymphoblastic leukemia relationships to normal and malignant lymphocyte proliferation,” Leukemia Research, vol. 33, no. 9, pp. 1217–1223, 2009. View at Publisher · View at Google Scholar · View at Scopus
  128. K. J. Mavrakis, A. L. Wolfe, E. Oricchio et al., “Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia,” Nature Cell Biology, vol. 12, no. 4, pp. 372–379, 2010. View at Publisher · View at Google Scholar · View at Scopus